Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways.
about
Vitamin D and allergic airway disease shape the murine lung microbiome in a sex-specific manner.Host genetic variation in mucosal immunity pathways influences the upper airway microbiome.The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.Improving the diagnosis of eosinophilic asthma.Airway Microbiota and the Implications of Dysbiosis in Asthma.The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases.Atopic asthmatic immune phenotypes associated with airway microbiota and airway obstruction.Microbiome and asthma.The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma.Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes.Subgroup differences in the associations between dog exposure during the first year of life and early life allergic outcomes.Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.Bacterial biogeography of adult airways in atopic asthma.Gut microbiota relationships to lung function and adult asthma phenotype: a pilot studyDeterminants of the Nasal Microbiome: Pilot Study of Effects of Intranasal Medication Use
P2860
Q37272779-DB3382D1-2811-4C5E-B738-1C0F88BA4EFEQ37618401-252D6D4F-C78E-4D63-8105-F348CA1DEF8AQ38622649-FF10BB69-926C-43E5-BDD0-0B6F3B85B46CQ38750982-0C293772-395D-4C9C-BEA9-C6CAC04F89A2Q38795934-B24AA620-1053-4C67-9F0B-650AE90D42B4Q38821540-CDDCEEAC-DA32-45FE-9620-771F95007816Q38890722-25D0726A-CCAE-4552-B4BD-0FB4A193C9FEQ38911712-323CAC53-E507-4A64-AA12-FE273DAFCF3DQ43504466-80DB163D-A5B5-4D52-8C3E-52A6038248DFQ47228960-3061B2D2-C71A-4A7E-AC71-D1DDB40CF5CFQ47638694-535D3045-0374-4B91-B53B-0F88D168DF06Q47704287-EAD96839-6F4C-4072-85C6-925747BD938AQ51549895-5AAE77C1-62CC-4CD0-9B01-BB1A3BC2A57FQ52371735-8FCCA54B-C6FE-4EC7-AAC3-9D48E1C7650EQ55378029-3AA70AF7-48B2-46A4-80D4-79CDA823A6E7Q57070672-8C7B6340-93B1-4E78-8A96-8D29D8CCE2E4Q58803293-7F5D3B44-DCEE-4688-A9E2-2845375B9EE8
P2860
Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Corticosteroid therapy and air ...... r lavage in asthmatic airways.
@ast
Corticosteroid therapy and air ...... r lavage in asthmatic airways.
@en
type
label
Corticosteroid therapy and air ...... r lavage in asthmatic airways.
@ast
Corticosteroid therapy and air ...... r lavage in asthmatic airways.
@en
prefLabel
Corticosteroid therapy and air ...... r lavage in asthmatic airways.
@ast
Corticosteroid therapy and air ...... r lavage in asthmatic airways.
@en
P2093
P2860
P921
P1476
Corticosteroid therapy and air ...... ar lavage in asthmatic airways
@en
P2093
Anne I Sperling
D Kyle Hogarth
Darcy R Denner
Edward T Naureckas
Jack A Gilbert
Jamee Castillo
Julia B Becker
Julian Solway
Justin Oldham
Steven R White
P2860
P304
1398-1405.e3
P356
10.1016/J.JACI.2015.10.017
P407
P577
2015-11-25T00:00:00Z